Background: Recent studies demonstrate that botulinum toxin type A (BTX-A) decreases palmar hyperhidrosis.

Objective: To evaluate the efficacy and safety of BTX-A for palmar hyperhidrosis.

Methods: Patients (n = 19) received injections of placebo (normal saline) in one hand and BTX-A in the other. Assessments included gravimetric measurement of sweat production and physician's and patient's rating of severity. Safety evaluations included measuring grip strength. Preliminary 28-day results are reported.

Results: The mean percentage decrease in gravimetric measurement at day 28 was significantly greater with BTX-A versus placebo. One hundred percent of 17 patients rated the treatment as successful, while only 12% (2/17) rated placebo injection successful. Grip and hand strength were unchanged with either treatment. Only 21% (4/19) reported mild adverse events.

Conclusion: BTX-A injections produce significant improvements in palmar hyperhidrosis without a concomitant decrease in grip or dexterity, or the occurrence of serious adverse events.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1524-4725.2002.02039.xDOI Listing

Publication Analysis

Top Keywords

efficacy safety
8
botulinum toxin
8
toxin type
8
palmar hyperhidrosis
8
gravimetric measurement
8
btx-a
5
safety botulinum
4
type treatment
4
palmar
4
treatment palmar
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!